Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2025-12-24 @ 6:29 PM
NCT ID:
NCT01537068
Eligibility Criteria:
Inclusion Criteria:
* Male and female outpatients 20 to 65 years of age, inclusive
* Principal DSM-5 diagnosis of unipolar non-major Chronic Depressive Disorder (including Major Depression in partial remission, Major Depression, residual, Dysthymic Disorder, or Depressive Disorder NOS)
* Minimum of 2 years duration of the current episode of depressive disorder.
* Score of 12 or higher on the Hamilton Depression Scale (24 items) at baseline
Exclusion Criteria:
* Full remission of depression in past 24 months
* Current major depression diagnosis, psychotic illness
* Current risk of suicide
* Drug or alcohol abuse/dependence in past 6 months
* Active medical illness
* Prior nonresponse to desvenlafaxine
* Medical illness contraindicating use of desvenlafaxine
* Current or planned pregnancy during study period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
65 Years
Study:
NCT01537068
Study Brief:
Protocol Section:
NCT01537068